97 related articles for article (PubMed ID: 8906107)
21. [Atopic dermatitis and eosinophils].
Yoshida H; Maeda K; Tanaka Y; Anan S
Arerugi; 1991 May; 40(5):489-93. PubMed ID: 1883263
[No Abstract] [Full Text] [Related]
22. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.
Jenerowicz D; Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(2):73-80. PubMed ID: 16859611
[TBL] [Abstract][Full Text] [Related]
23. [Eosinophilic granulocytes and their significance in allergic diseases].
Bruijnzeel PL; Rihs S; Betz S
Schweiz Med Wochenschr; 1992 Feb; 122(6):173-80. PubMed ID: 1535993
[TBL] [Abstract][Full Text] [Related]
24. Digestion of the fifth component of complement by eosinophil lysosomal enzymes. Production of eosinophil specific chemotactic activity.
Ogawa H; Kunkel SL; Fantone JC; Ward PA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(2):149-57. PubMed ID: 6119842
[TBL] [Abstract][Full Text] [Related]
25. Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects.
Raap U; Deneka N; Bruder M; Kapp A; Wedi B
Clin Exp Allergy; 2008 Sep; 38(9):1493-8. PubMed ID: 18647313
[TBL] [Abstract][Full Text] [Related]
26. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
[TBL] [Abstract][Full Text] [Related]
27. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.
Hirashima M; Tashiro K; Sakata K; Hirashima M
Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462
[TBL] [Abstract][Full Text] [Related]
28. Eosinophil chemotactic lymphokine produced by spleen cells of Schistosoma japonicum-infected mice.
Owhashi M; Nawa Y
Int Arch Allergy Appl Immunol; 1987; 82(1):20-5. PubMed ID: 3100450
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
Tamura N; Agrawal DK; Townley RG
J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
[TBL] [Abstract][Full Text] [Related]
30. Expansion of activated eosinophils in infants with severe atopic dermatitis.
Toma T; Mizuno K; Okamoto H; Kanegane C; Ohta K; Ikawa Y; Miura M; Kuroda M; Niida Y; Koizumi S; Yachie A
Pediatr Int; 2005 Feb; 47(1):32-8. PubMed ID: 15693863
[TBL] [Abstract][Full Text] [Related]
31. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
Goetzl EJ
Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
[TBL] [Abstract][Full Text] [Related]
32. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
33. Epinastine inhibits eosinophil chemotaxis and adhesion molecules in atopic dermatitis.
Matsukura M; Yajima A; Yamazaki F; Yudate T; Yamada H; Tezuka T
Skin Pharmacol Appl Skin Physiol; 2003; 16(6):405-10. PubMed ID: 14528065
[TBL] [Abstract][Full Text] [Related]
34. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide.
Lantero S; Sacco O; Scala C; Morelli MC; Rossi GA
Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423
[TBL] [Abstract][Full Text] [Related]
35. The regulation of tissue eosinophilia. III. In vitro production of eosinophil-directed chemotactic inhibitory factor by T lymphocytes of complete Freund's adjuvant-treated guinea-pigs.
Tashiro K; Sakata K; Hirashima M; Hayashi H
Immunology; 1985 May; 55(1):115-24. PubMed ID: 3873403
[TBL] [Abstract][Full Text] [Related]
36. Peripheral blood eosinophilia in atopic dermatitis.
Jenerowicz D; Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):47-52. PubMed ID: 17992457
[TBL] [Abstract][Full Text] [Related]
37. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
[TBL] [Abstract][Full Text] [Related]
38. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.
Wu KG; Li TH; Chen CJ; Cheng HI; Wang TY
Int J Immunopathol Pharmacol; 2011; 24(1):15-23. PubMed ID: 21496383
[TBL] [Abstract][Full Text] [Related]
39. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.
Taha RA; Minshall EM; Leung DY; Boguniewicz M; Luster A; Muro S; Toda M; Hamid QA
J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183
[TBL] [Abstract][Full Text] [Related]
40. The role of chemokines in cutaneous allergic inflammation.
Schröder JM; Mochizuki M
Biol Chem; 1999; 380(7-8):889-96. PubMed ID: 10494838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
